The pharmaceutical industry is under increasing pressure to reduce emissions, yet the greatest challenge lies in Scope 3, particularly in upstream chemical manufacturing. However, current approaches often rely on high-level carbon accounting methods that lack the accuracy and granularity needed to drive meaningful, actionable change.

This symposium brings together C-level executives, technical leaders, industry associations, and academic experts to explore a fundamental question:

“How can pharmaceutical decarbonization move from ambition to actionable, process-level transformation?”

Key Topics 

• How continuous flow technologies provide a system-level foundation for transformation, integrating reaction science, analytics, modeling, and engineering into a unified, scalable platform
• How process-level carbon intelligence (PCF) can make Scope 3 emissions measurable and actionable
• The intersection of carbon reduction, cost efficiency, and process safety

What Makes This Discussion Different 

Rather than focusing on reporting or high-level targets, this symposium emphasizes:

• Process-level solutions
• Predictive and data-driven approaches
• Industrial case insights from real manufacturing environments

Take the opportunity to also visit Pharmablock Sciences (Switzerland) for an exclusive site tour on June 24, 2026.